Quick Answer
Arcturus Therapeutics Holdings Inc. reported Common Stock Shares Outstanding of 28.41 million shares for the year ending 2025.
- Arcturus Therapeutics Holdings Inc. showed an increase of +5.2% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Arcturus Therapeutics Holdings Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2018 to 2025), Arcturus Therapeutics Holdings Inc.'s Common Stock Shares Outstanding has grown by 165.1%.
- Historical annual values: Fiscal year 2025: 28.41 million shares | Fiscal year 2024: 27.00 million shares | Fiscal year 2023: 26.83 million shares | Fiscal year 2022: 26.56 million shares | Fiscal year 2021: 26.37 million shares | Fiscal year 2020: 26.19 million shares | Fiscal year 2019: 15.14 million shares | Fiscal year 2018: 10.72 million shares.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: